HeartSciences Inc.
HeartSciences Inc. (HSCS) Revenue
Annual & quarterly revenue history · segment & region breakdown
HSCS · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsHeartSciences Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 76.61% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2020 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-04-30 | $0.00B | -$0.00B | -76.61% |
| 2024-04-30 | $0.00B | +$0.00B | +261.17% |
| 2023-04-30 | $0.00B | -$0.00B | -64.17% |
| 2022-04-30 | $0.00B | -$0.00B | -43.86% |
| 2021-04-30 | $0.00B | -$0.00B | -60.11% |
| 2020-04-30 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income HeartSciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
HeartSciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from HeartSciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HSCS revenue · 4 questionsHSCS's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 76.61% year-over-year from $0.00B in FY2025.
▸ Source: FMP · HeartSciences Inc. SEC filings · GAAP · HeartSciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026